344 related articles for article (PubMed ID: 32212206)
1. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.
Westrich JA; Vermeer DW; Colbert PL; Spanos WC; Pyeon D
Mol Carcinog; 2020 Jul; 59(7):794-806. PubMed ID: 32212206
[TBL] [Abstract][Full Text] [Related]
2. CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8
Westrich JA; Vermeer DW; Silva A; Bonney S; Berger JN; Cicchini L; Greer RO; Song JI; Raben D; Slansky JE; Lee JH; Spanos WC; Pyeon D
Oncogene; 2019 Nov; 38(46):7166-7180. PubMed ID: 31417179
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
4. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy.
Giacobbi NS; Mullapudi S; Nabors H; Pyeon D
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400076
[TBL] [Abstract][Full Text] [Related]
5. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals.
Hara T; Tanegashima K
J Biochem; 2012 May; 151(5):469-76. PubMed ID: 22437940
[TBL] [Abstract][Full Text] [Related]
7. CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
Kouzeli A; Collins PJ; Metzemaekers M; Meyrath M; Szpakowska M; Artinger M; Struyf S; Proost P; Chevigne A; Legler DF; Eberl M; Moser B
Front Immunol; 2020; 11():561404. PubMed ID: 33123134
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
[TBL] [Abstract][Full Text] [Related]
9. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.
Gibbs C; So JY; Ahad A; Michalowski AM; Son DS; Li Y
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012586
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome.
Peterson FC; Thorpe JA; Harder AG; Volkman BF; Schwarze SR
J Mol Biol; 2006 Nov; 363(4):813-22. PubMed ID: 16987528
[TBL] [Abstract][Full Text] [Related]
12. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
13. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected].
Izukuri K; Suzuki K; Yajima N; Ozawa S; Ito S; Kubota E; Hata R
Transgenic Res; 2010 Dec; 19(6):1109-17. PubMed ID: 20333465
[TBL] [Abstract][Full Text] [Related]
14. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.
McKinnon CM; Lygoe KA; Skelton L; Mitter R; Mellor H
Oncogene; 2008 Nov; 27(54):6856-65. PubMed ID: 18762809
[TBL] [Abstract][Full Text] [Related]
15. Expression and effect of CXCL14 in colorectal carcinoma.
Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X
Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992
[TBL] [Abstract][Full Text] [Related]
16. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
17. Identification of tissue-specific expression of CXCL14 in black rockfish (Sebastes schlegelii).
Bae H; Yang C; Lim W; Song G
Fish Shellfish Immunol; 2021 May; 112():135-142. PubMed ID: 33746059
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues.
Meuter S; Moser B
Cytokine; 2008 Nov; 44(2):248-55. PubMed ID: 18809336
[TBL] [Abstract][Full Text] [Related]
19. C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression.
Yang XY; Ozawa S; Kato Y; Maehata Y; Izukuri K; Ikoma T; Kanamori K; Akasaka T; Suzuki K; Iwabuchi H; Kurata SI; Katoh I; Sakurai T; Kiyono T; Hata RI
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31014014
[TBL] [Abstract][Full Text] [Related]
20. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Clin Cancer Res; 2019 Jun; 25(12):3702-3717. PubMed ID: 30850359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
